Infliximab vs Ustekinumab in Biologic Naive Crohn's Disease. Huang X, Li X. Clin Gastroenterol Hepatol 2022;20:e1216.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang X, Li X. Infliximab vs Ustekinumab in Biologic Naive Crohn's Disease. Clin Gastroenterol Hepatol 2022;20:e1216.
PMID: 33991689